UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Executive salaries highest at Samsung Biologics, Celltrion
Samsung Biologics recorded the widest salary gap between its executives and...
by Jeong Sae-im
|
2020-04-09 11:13
라인
Review of cancer drug benefits delayed amid social distancing
The government has postponed the health authorities’ meeting for a review o...
by Kim Yun-mi
|
2020-04-08 13:46
라인
Jeil’s oral cancer treatment wins extended indication for NSCLC
Jeil Pharmaceutical said Monday that its oral anticancer drug, Ts-1, has ob...
by Shim Hyun-tai
|
2020-04-06 15:33
라인
Pfizer, MSD put off reorganizing due to COVID-19
Pfizer and MSD have postponed their scheduled organizational reshuffle beca...
by Kim Yun-mi
|
2020-04-03 17:09
라인
GC Pharma to supply plasma treatment for COVID-19 this year
GC Pharma said Thursday that it plans to commercialize GC5131A, the world...
by Shim Hyun-tai
|
2020-04-02 18:11
라인
Genexine to release results of using Hyleukin-7 & Keytruda at ASCO
Genexine said Wednesday that its poster presentation has won the approval f...
by Shim Hyun-tai
|
2020-04-02 17:01
라인
AptaBio wins patent for blood cancer therapy
AptaBio, a biopharmaceutical developer of anticancer and diabetic complicat...
by Shim Hyun-tai
|
2020-04-02 16:17
라인
Venclexta extended survival in first-line acute myeloid leukemia
AbbVie said combining Venclexta (ingredient: venetoclax), a treatment for c...
by Kim Yoon-mi
|
2020-04-02 15:31
라인
‘More public-private partnership needed to spur research of less-profitable areas’
The new coronavirus pandemic has affected more than 800,000 people around t...
by You Ji-young
|
2020-04-01 18:58
라인
GC partner applies for permit of Hunterase ICV to Japan
GC Pharma said Tuesday that its partner, Clinigen K.K., has applied for the...
by Shim Hyun-tai
|
2020-04-01 18:47
라인
Fresinius Medical Care names new CEO
Fresenius Medical Care Korea said Wednesday that it has appointed Kim Hee-g...
by Shim Hyun-tai
|
2020-04-01 14:38
라인
Court rejects arrest warrant request for Medytox CEO
A local court has rejected the prosecution’s warrant request to arrest Medy...
by Jeong Sae-im
|
2020-03-31 17:51
라인
JW wins extended indication for hemophilia A treatment
JW Pharmaceutical said Tuesday that the Ministry of Food and Drug Safety ha...
by Lee Han-soo
|
2020-03-31 10:57
라인
Mitsubishi Tanabe Pharma Korea to market Australian insomnia treatment
Mitsubishi Tanabe Pharma Korea said that it would import and market Zolpimi...
by Lee Han-soo
|
2020-03-31 10:57
라인
GC LabCell to develop COVID-19 treatment using NK-cell
Green Cross LabCell said that it has begun research into a COVID-19 medicat...
by Shim Hyun-tai
|
2020-03-30 16:02
라인
CJ Healthcare changes name to HK inno.N
CJ Healthcare, a subsidiary of Kolmar Korea, said that it has changed the c...
by Lee Han-soo
|
2020-03-30 14:35
라인
SK, Sanofi applies for IND status to test pneumococcal vaccine
SK Bioscience and Sanofi Pasteur said they have submitted an investigationa...
by Lee Han-soo
|
2020-03-30 12:38
라인
Pharmicell shares skyrocket on soaring US demand for testing kits
Pharmicell’s stock prices shot up for two consecutive days on Friday, as in...
by Jeong Sae-im
|
2020-03-27 17:27
라인
AbbVie's Venclexta wins regulator’s OK for leukemia treatment
AbbVie's Venclexta (Ingredient: venetoclax) has acquired approval from ...
by Shim Hyun-tai
|
2020-03-27 17:26
라인
State cancer center finds new material to kill cancer cells
A group of researchers at the National Cancer Center (NCC) has discovered a...
by Shim Hyun-tai
|
2020-03-26 18:20
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top